drugset / Trial / NCT05609812
Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the study is to evaluate the effect of atacicept compared to placebo on changes to renal response in adult subjects with LN.
Timeline
- Start
- 2022-11-02
- Primary completion
- 2026-03-15
- Completion
- 2028-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atacicept | Protein / enzyme biologic | — | Subcutaneous |